A registry of women who have been pregnant while receiving anticoagulant treatment with a DOAC is an ongoing project of the SSC Subcommittee on Women’s Issues in Thrombosis and Hemostasis. If you have eligible patients, we would appreciate your participation in the study. The goal is to assess the effects of exposure to DOACs in utero on the fetus and the child in the long-term. It is a multicenter, international, observational cohort study, and the registry is designed to collect both retrospective and prospective data. Eligibility criteria for enrollment are women with 1) confirmed use of a DOAC, and 2) a confirmed pregnancy during DOAC use.
This registry is led by Jan Beyer (University Hospital Carl Gustav Carus Dresden, Germany), Saskia Middeldorp (AMC, the Netherlands) and Peter Verhamme (KU Leuven, Belgium), under the auspices and with the support of the SSC of the ISTH.